Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 6/20 | 0.49 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.49 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | SELL | P14151 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | CD69 | Q07108 | 1/20 | 0.40 |
| ▸ | SELP | P16109 | 2/20 | 0.39 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.38 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.38 |
| ▸ | SIGLEC7 | Q9Y286 | 3/20 | 0.37 |
| ▸ | BMP2 | P12643 | 1/20 | 0.37 |
| ▸ | VEGFA | P15692 | 1/20 | 0.37 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.37 |
| ▸ | SHH | Q15465 | 1/20 | 0.37 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17586067 | 0.87 | LGALS8 (0.46) | LGALS3LGALS8LGALS4MAPK1SELL | |
| SCHEMBL17586060 | 0.78 | LGALS8 (0.62) | LGALS3LGALS8LGALS4MAPK1SELL | |
| SCHEMBL17563420 | 0.76 | LGALS3 (0.60) | LGALS3LGALS8LGALS4MAPK1SELL | |
| SCHEMBL17572910 | 0.75 | LGALS8 (0.58) | LGALS3LGALS8LGALS4MAPK1SELL | |
| SCHEMBL19490292 | 0.75 | SIGLEC7 (0.65) | SELLSELPSIGLEC7 | |
| SCHEMBL21064189 | 0.75 | SIGLEC7 (0.51) | LGALS3LGALS8LGALS4MAPK1SELL | |
| SCHEMBL21064185 | 0.74 | SELL (0.49) | LGALS3LGALS8LGALS4MAPK1SELL | |
| SCHEMBL14400216 | 0.73 | MAPK1 (0.53) | LGALS3LGALS8LGALS4MAPK1ALDH1A1 | |
| SCHEMBL17586068 | 0.72 | SELL (0.53) | LGALS3LGALS8LGALS4MAPK1SELL | |
| SCHEMBL8744636 | 0.72 | MAPK1 (0.65) | LGALS3LGALS8LGALS4MAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10307471-B2 | Immunity inducer for saccharide antigens | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2019-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10307471-B2 | Immunity inducer for saccharide antigens | CD14, CD4, CD69 | LGALS3 248/4885LGALS8 193/4885LGALS4 122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.